Pneumococcal Conjugate and Plain Polysaccharide Vaccines Have Divergent Effects on Antigen-Specific B Cells
Background. A 23-valent unconjugated pneumococcal polysaccharide vaccine (23vP), routinely administered at the age of 65, has limited effectiveness, and revaccination induces attenuated antibody responses. It is not known whether pneumococcal polysaccharide-protein conjugated vaccines (PCV), althoug...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Oxford University Press
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3324398/ |
id |
pubmed-3324398 |
---|---|
recordtype |
oai_dc |
spelling |
pubmed-33243982012-04-12 Pneumococcal Conjugate and Plain Polysaccharide Vaccines Have Divergent Effects on Antigen-Specific B Cells Clutterbuck, Elizabeth A. Lazarus, Rajeka Yu, Ly-Mee Bowman, Jaclyn Bateman, Elizabeth A. L. Diggle, Linda Angus, Brian Peto, Tim E. Beverley, Peter C. Mant, David Pollard, Andrew J. Major Articles and Brief Reports Background. A 23-valent unconjugated pneumococcal polysaccharide vaccine (23vP), routinely administered at the age of 65, has limited effectiveness, and revaccination induces attenuated antibody responses. It is not known whether pneumococcal polysaccharide-protein conjugated vaccines (PCV), although highly effective in infants, offer any immunological advantages over 23vP in adults. Oxford University Press 2012-05-01 2012-03-28 /pmc/articles/PMC3324398/ /pubmed/22457293 http://dx.doi.org/10.1093/infdis/jis212 Text en © The Author 2012. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com. http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
repository_type |
Open Access Journal |
institution_category |
Foreign Institution |
institution |
US National Center for Biotechnology Information |
building |
NCBI PubMed |
collection |
Online Access |
language |
English |
format |
Online |
author |
Clutterbuck, Elizabeth A. Lazarus, Rajeka Yu, Ly-Mee Bowman, Jaclyn Bateman, Elizabeth A. L. Diggle, Linda Angus, Brian Peto, Tim E. Beverley, Peter C. Mant, David Pollard, Andrew J. |
spellingShingle |
Clutterbuck, Elizabeth A. Lazarus, Rajeka Yu, Ly-Mee Bowman, Jaclyn Bateman, Elizabeth A. L. Diggle, Linda Angus, Brian Peto, Tim E. Beverley, Peter C. Mant, David Pollard, Andrew J. Pneumococcal Conjugate and Plain Polysaccharide Vaccines Have Divergent Effects on Antigen-Specific B Cells |
author_facet |
Clutterbuck, Elizabeth A. Lazarus, Rajeka Yu, Ly-Mee Bowman, Jaclyn Bateman, Elizabeth A. L. Diggle, Linda Angus, Brian Peto, Tim E. Beverley, Peter C. Mant, David Pollard, Andrew J. |
author_sort |
Clutterbuck, Elizabeth A. |
title |
Pneumococcal Conjugate and Plain Polysaccharide Vaccines Have Divergent Effects on Antigen-Specific B Cells |
title_short |
Pneumococcal Conjugate and Plain Polysaccharide Vaccines Have Divergent Effects on Antigen-Specific B Cells |
title_full |
Pneumococcal Conjugate and Plain Polysaccharide Vaccines Have Divergent Effects on Antigen-Specific B Cells |
title_fullStr |
Pneumococcal Conjugate and Plain Polysaccharide Vaccines Have Divergent Effects on Antigen-Specific B Cells |
title_full_unstemmed |
Pneumococcal Conjugate and Plain Polysaccharide Vaccines Have Divergent Effects on Antigen-Specific B Cells |
title_sort |
pneumococcal conjugate and plain polysaccharide vaccines have divergent effects on antigen-specific b cells |
description |
Background. A 23-valent unconjugated pneumococcal polysaccharide vaccine (23vP), routinely administered at the age of 65, has limited effectiveness, and revaccination induces attenuated antibody responses. It is not known whether pneumococcal polysaccharide-protein conjugated vaccines (PCV), although highly effective in infants, offer any immunological advantages over 23vP in adults. |
publisher |
Oxford University Press |
publishDate |
2012 |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3324398/ |
_version_ |
1611520429032210432 |